OKYO Pharma (OKYO) Invested Capital (2021 - 2025)

OKYO Pharma (OKYO) has 5 years of Invested Capital data on file, last reported at $185795.0 in Q3 2025.

• Invested Capital for Q3 2025 came in at $185795.0, up 100.13% year-over-year; the trailing twelve-month figure through Mar 2025 was -$4.7 million (up 15.05% YoY), and the FY2025 annual result was -$4.7 million, up 15.05% from the prior year.
• Invested Capital rose to $185795.0 in Q3 2025 per OKYO's latest filing, from -$4.7 million in the prior quarter.
• Over five years, Invested Capital peaked at $135.9 million in Q3 2023 and troughed at -$145.2 million in Q3 2024.
• A 5-year average of -$1.6 million and a median of -$933721.0 in 2023 frame the typical range for Invested Capital.
• The sharpest annual moves came in 2024 and 2025: Invested Capital slumped 206.84% in 2024, then surged 100.13% in 2025.
• A 5-year view of Invested Capital shows it stood at $5.3 million in 2021, then plunged by 44.59% to $2.9 million in 2022, then jumped by 4510.99% to $135.9 million in 2023, then tumbled by 206.84% to -$145.2 million in 2024, then jumped by 100.13% to $185795.0 in 2025.
• Business Quant data shows OKYO's Invested Capital at $185795.0 in Q3 2025, -$4.7 million in Q1 2025, and -$145.2 million in Q3 2024.